Further analysis of human glioma tissue revealed similar differentiation patterns, with 20–57% of tumor-infiltrating CD8+ T cells expressing αE(CD103)β7 integrin compared to fewer than 5% of CD8+ T cells in peripheral blood (164). The gene discussed is CD8A; the disease is central nervous system cancer.